Rezolute Inc (NASDAQ:RZLT) Presents Positive Results from the Phase 2b RIZE Study of RZ358: Stock Rallies

March 24, 2022

Clinical stage biotech company Rezolute Inc (NASDAQ:RZLT) has seen its stock go into a remarkable rally over the course of the past week and clock gains of as much as 70% during the period. Trading Data On Wednesday, RZLT stock gained 7.34% to $3.95 with 8.8 million shares, compared to its average volume of 177K shares. The stock moved within a range of $3.2450 – 4.6400 after opening trade at…